No Data
Syros Pharmaceuticals Gave Notice To Qiagen Manchester Limited Of Its Election To Terminate The Master Collaboration Agreement Dated March 7, 2022
Syros Pharmaceuticals Faces Financial Struggles Amid Key Challenges
Express News | Syros Pharmaceuticals Inc - Appointment of Gerald Quirk, Esq., as President & CEO
Express News | Syros - Notified Conley Chee,CEO ,Jason Haas,CFO, David Roth, Chief Medical Officer That Employment of Such Officers Will Terminate Without Cause
Express News | Syros Pharmaceuticals Inc - Committed to Implementing a Reduction in Workforce by Approximately 94%
Express News | Syros Pharmaceuticals Inc - on Nov 15, Paid $33.5 Mln to Oxford in Partial Satisfaction of Its Obligations Under Loan Agreement
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
